Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ALK molecular phenotype in non-small cell lung cancer: CT radiogenomic characterization.

Radiology - 1 Aug 2014

Yamamoto Shota, Korn Ronald L, Oklu Rahmi, Migdal Christopher, Gotway Michael B, Weiss Glen J, Iafrate A John, Kim Dong-Wan, Kuo Michael D

Abstract excerpt

PURPOSE: To present a radiogenomic computed tomographic (CT) characterization of anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC) (ALK+). MATERIALS AND METHODS: In this HIPAA-compliant institutional review board-approved retrospective study, CT studies, ALK status, and clinical-pathologic data in 172 patients with NSCLC from three institutions were analyzed. A screen of 24 CT image...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anaplastic Lymphoma Kinase
Share to Crizotinib

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Proto-Oncogene Proteins p21(ras)

Share to Pyrazoles

Share to Pyridines

Share to ras Proteins

Share to Receptor Protein-Tyrosine Kinases

Share to Tomography, X-Ray Computed

Source

Identifiers

PMID: 24885982
DOI: 10.1148/radiol.14140789

Genes

ALK

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ALK molecular phenotype in non-small cell lung cancer: CT radiogenomic characterization.PMID 24885982Read ↗

An Enhanced CT-based Radiomics Model for Predicting the Anaplastic Lymphoma Kinase Mutation Status in Lung Adenocarcinoma.Semantic proximity Read ↗

CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer.Semantic proximity Read ↗

ALK in lung cancer: past, present, and future.Semantic proximity Read ↗

A Radio-Genomics Biomarker for Precision Epidermal Growth Factor Receptor Mutation Targeting Therapy in Non-Small Cell Lung CancerSemantic proximity Read ↗

A radio-genomics biomarker for precision epidermal growth factor receptor mutation targeting therapy in non-small cell lung cancer.Semantic proximity Read ↗

Computed Tomography-Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid NoduleSemantic proximity Read ↗

EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype.Semantic proximity Read ↗

Treatment for ALK-mutated non-small-cell lung cancer: a new miracle in the research race.Semantic proximity Read ↗

Correlation Between Tumor Mutational Burden and CT Radiographic Features in Lung Adenocarcinoma: A Diagnostic Accuracy StudySemantic proximity Read ↗

Value of CT features for predicting EGFR mutations and ALK positivity in patients with lung adenocarcinoma.Semantic proximity Read ↗

Radiologic Characteristics of Surgically Resected Non-Small Cell Lung Cancer With ALK Rearrangement or EGFR Mutations.Semantic proximity Read ↗

Advanced adenocarcinoma of the lung: comparison of CT characteristics of patients with anaplastic lymphoma kinase gene rearrangement and those with epidermal growth factor receptor mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.